Andrew Bellinger - Chief Scientific Officer at Verve Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
VERV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Bellinger since 11/5/2023

Holdings reported by Andrew Bellinger for Verve Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 45K $450K $10.00 Feb 14, 2024 Direct Common Stock
Stock Option (right to buy) 180K Feb 14, 2024 Direct Common Stock

Transactions reported by Andrew Bellinger for Verve Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.